RT Journal Article
SR Electronic
T1 A Queuing Model for Ventilator Capacity Management during the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.17.21253488
DO 10.1101/2021.03.17.21253488
A1 Zimmerman, Samantha
A1 Rutherford, Alexander R.
A1 van der Waall, Alexa
A1 Norena, Monica
A1 Dodek, Peter
YR 2021
UL http://medrxiv.org/content/early/2021/03/21/2021.03.17.21253488.abstract
AB We present a queue model to inform ventilator capacity management under different COVID-19 pandemic scenarios. Our model was used to support ventilator capacity planning during the first wave of the COVID-19 epidemic in British Columbia (BC), Canada. The core of our framework is an extended Erlang loss model, which incorporates COVID-19 case projections, along with the proportion of cases requiring a ventilator, the delay from symptom onset to ventilation, non-COVID-19 ventilator demand, and ventilation time. We implemented our model using discrete event simulation to forecast ventilator utilization. The results predict when capacity would be reached and the rate at which patients would be unable to access a ventilator. We further determined the number of ventilators required to meet a performance indicator target for ventilator access. We applied our model to BC by calibrating to the BC Intensive Care Unit Database and by using local epidemic projections. Epidemic scenarios with and without reduced transmission, due to social distancing and other behavioral changes, were used to link public health interventions to operational impacts on ventilator utilization. The results predict that reduced transmission could potentially avert up to 50 deaths per day by ensuring that ventilator capacity would likely not be reached. Without reduced transmission, an additional 181 ventilators would be required to meet our performance indicator target that 95% of patients can access a ventilator immediately. Our model provides a tool for policy makers to quantify the interplay between public health interventions, necessary critical care resources, and performance indicators for patient access.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a Partnership & Innovation Grant from the British Columbia Ministry of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Office of Research Ethics, Simon Fraser University, approved this study on the grounds that it is Quality Improvement / Quality Assurance.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesA github reference is given in the manuscript for BC Centre for Disease Control case projections used in the model. https://github.com/bcgov/epi.branch.sim